Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ohshima

Showing results (321-330 of 395) with videos related to

Pageof 40
Sort By:
Histopathology|February 15, 2000
Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic moleculesK Ohshima, S Haraoka, N Harada, et al.
Leukemia & Lymphoma|October 24, 2000
Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferationJ Suzumiya, K Ohshima, M Kanda, et al.
International Journal of Cancer|June 8, 2001
Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasionK Ohshima, K Muta, M Nakashima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1991
[Intestinal T-cell lymphoma (so-called malignant histiocytosis of the intestine) complicated by multiple perforations]S Sadamura, T Chihara, K Shibata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 2010
Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphomaN Niitsu, M Okamoto, J-I Tamaru, et al.
Nihon Naibunpi Gakkai Zasshi|May 20, 1992
[Mechanism of suppressed prolactin secretion due to medium hyperosmolarity--the importance of Ca2+ influx]N Sato, M A Greer, Y Shimomura, et al.
Histopathology|August 9, 2001
CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosisK Ohshima, C Kawasaki, H Muta, et al.
International Journal of Oncology|July 11, 2001
Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaBK Ohshima, H Muta, C Kawasaki, et al.
Veterinary Pathology|September 1, 1995
Immunohistologic studies on subpopulations of lymphocytes in cattle with enzootic bovine leukosisT Chiba, M Hiraga, Y Aida, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 10, 2010
Impaired glucose tolerance, but not impaired fasting glucose, is a risk factor for early-stage atherosclerosisT Ando, S Okada, Y Niijima, et al.
Pageof 40

Showing results (321-330 of 395) with videos related to

Sort By:
Pageof 40
Histopathology|February 15, 2000
Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic moleculesK Ohshima, S Haraoka, N Harada, et al.
Leukemia & Lymphoma|October 24, 2000
Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferationJ Suzumiya, K Ohshima, M Kanda, et al.
International Journal of Cancer|June 8, 2001
Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasionK Ohshima, K Muta, M Nakashima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1991
[Intestinal T-cell lymphoma (so-called malignant histiocytosis of the intestine) complicated by multiple perforations]S Sadamura, T Chihara, K Shibata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 2010
Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphomaN Niitsu, M Okamoto, J-I Tamaru, et al.
Nihon Naibunpi Gakkai Zasshi|May 20, 1992
[Mechanism of suppressed prolactin secretion due to medium hyperosmolarity--the importance of Ca2+ influx]N Sato, M A Greer, Y Shimomura, et al.
Histopathology|August 9, 2001
CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosisK Ohshima, C Kawasaki, H Muta, et al.
International Journal of Oncology|July 11, 2001
Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaBK Ohshima, H Muta, C Kawasaki, et al.
Veterinary Pathology|September 1, 1995
Immunohistologic studies on subpopulations of lymphocytes in cattle with enzootic bovine leukosisT Chiba, M Hiraga, Y Aida, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 10, 2010
Impaired glucose tolerance, but not impaired fasting glucose, is a risk factor for early-stage atherosclerosisT Ando, S Okada, Y Niijima, et al.
Pageof 40